Directive clinique no 442 : Retard de croissance intra-utérin : Dépistage, diagnostic et prise en charge en contexte de grossesse monofœtale

Gadsbøll, 2021, Crown-rump length measurement error: impact on assessment of growth, Ultrasound Obstet Gynecol, 58, 354, 10.1002/uog.23690 Melamed, 2021, FIGO (international Federation of Gynecology and Obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction, Int J Gynaecol Obstet, 152, 3, 10.1002/ijgo.13522 Hiersch, 2022, Should twin-specific growth charts be used to assess fetal growth in twin pregnancies?, Am J Obstet Gynecol, 227, 10, 10.1016/j.ajog.2022.01.027 Mifsud, 2014, Placental pathology in early-onset and late-onset fetal growth restriction, Fetal Diagn Ther, 36, 117, 10.1159/000359969 Redline, 2008, Placental pathology: a systematic approach with clinical correlations, Placenta, 29, S86, 10.1016/j.placenta.2007.09.003 McCowan, 2018, Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy, Am J Obstet Gynecol, 218, S855, 10.1016/j.ajog.2017.12.004 Lees, 2020, ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction, Ultrasound Obstet Gynecol, 56, 298, 10.1002/uog.22134 Lees, 2022, Clinical Opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach, Am J Obstet Gynecol, 226, 366, 10.1016/j.ajog.2021.11.1357 Hadlock, 1985, Estimation of fetal weight with the use of head, body, and femur measurements--a prospective study, Am J Obstet Gynecol, 151, 333, 10.1016/0002-9378(85)90298-4 Gordijn, 2016, Consensus definition of fetal growth restriction: a Delphi procedure, Ultrasound Obstet Gynecol, 48, 333, 10.1002/uog.15884 Riyami, 2011, Utility of head/abdomen circumference ratio in the evaluation of severe early-onset intrauterine growth restriction, J Obstet Gynaecol Can, 33, 715, 10.1016/S1701-2163(16)34956-8 Roeckner, 2021, Outcome-based comparison of SMFM and ISUOG definitions of fetal growth restriction, Ultrasound Obstet Gynecol, 57, 925, 10.1002/uog.23638 Molina, 2020, Validation of Delphi procedure consensus criteria for defining fetal growth restriction, Ultrasound Obstet Gynecol, 56, 61, 10.1002/uog.20854 Huang, 2010, Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome, Prenat Diagn, 30, 471, 10.1002/pd.2505 Papastefanou, 2021, Competing-risks model for prediction of small-for-gestational-age neonate from biophysical and biochemical markers at 11–13 weeks' gestation, Ultrasound Obstet Gynecol, 57, 52, 10.1002/uog.23523 Papastefanou, 2021, Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model, BJOG, 128, 2110, 10.1111/1471-0528.16815 Nowacka, 2022, Second-trimester contingent screening for small for gestational age neonates, Ultrasound Obstet Gynecol, 59, 177, 10.1002/uog.23730 Gagnon, 2008, Obstetrical complications associated with abnormal maternal serum markers analytes, J Obstet Gynaecol Can, 30, 918, 10.1016/S1701-2163(16)32973-5 Hui, 2012, Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review, J Obstet Gynaecol Can, 34, 142, 10.1016/S1701-2163(16)35157-X Hughes, 2019, The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome, Placenta, 81, 25, 10.1016/j.placenta.2019.04.005 Zhong, 2015, Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis, BMC Pregnancy Childbirth, 15, 191, 10.1186/s12884-015-0608-y Heazell, 2019, Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants, Cochrane Database Syst Rev, 5, CD012245 Yaron, 2002, Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome, Prenat Diagn, 22, 778, 10.1002/pd.407 Schwartz, 2014, First-trimester placental ultrasound and maternal serum markers as predictors of small-for-gestational-age infants, Am J Obstet Gynecol, 211, 253.e1, 10.1016/j.ajog.2014.02.033 Morris, 2017, Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis, Prenat Diagn, 37, 253, 10.1002/pd.5001 D'Antonio, 2013, Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications, Prenat Diagn, 33, 839, 10.1002/pd.4141 Alkazaleh, 2006, Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin, Am J Obstet Gynecol, 194, 821, 10.1016/j.ajog.2005.09.010 Proctor, 2009, Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A, Ultrasound Obstet Gynecol, 34, 274, 10.1002/uog.7308 Porat, 2013, Placental hyperinflation and the risk of adverse perinatal outcome, Ultrasound Obstet Gynecol, 42, 315, 10.1002/uog.12386 Ormesher, 2018, A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction, Pregnancy Hypertens, 14, 234, 10.1016/j.preghy.2018.03.007 McLaughlin, 2022, Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction, Am J Obstet Gynecol, 226, S1145, 10.1016/j.ajog.2021.08.027 McLaughlin, 2021, PlGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center, Hypertension, 77, 2057, 10.1161/HYPERTENSIONAHA.121.17047 Doulaveris, 2020, Fetal abdominal circumference in the second trimester and prediction of small for gestational age at birth, J Matern Fetal Neonatal Med, 33, 2415, 10.1080/14767058.2018.1554039 D'Ambrosio, 2019, Midtrimester isolated short femur and perinatal outcomes: a systematic review and meta-analysis, Acta Obstet Gynecol Scand, 98, 11, 10.1111/aogs.13470 Findley, 2018, Adverse perinatal conditions associated with prenatally detected fetal echogenic bowel in Nova Scotia, J Obstet Gynaecol Can, 40, 555, 10.1016/j.jogc.2017.09.017 Kingdom, 2018, A placenta clinic approach to the diagnosis and management of fetal growth restriction, Am J Obstet Gynecol, 218, S803, 10.1016/j.ajog.2017.11.575 Friebe-Hoffmann, 2019, Prenatally diagnosed single umbilical artery (SUA) - retrospective analysis of 1169 fetuses, Ultraschall Med, 40, 221, 10.1055/s-0043-123463 O'Quinn, 2020, Antenatal diagnosis of marginal and velamentous placental cord insertion and pregnancy outcomes, Obstet Gynecol, 135, 953, 10.1097/AOG.0000000000003753 Ebbing, 2013, Prevalence, risk factors and outcomes of velamentous and marginal cord insertions: a population-based study of 634,741 pregnancies, PLoS One, 8, 10.1371/journal.pone.0070380 Moraitis, 2021, Fetal umbilical artery Doppler as a tool for universal third trimester screening: a systematic review and meta-analysis of diagnostic test accuracy, Placenta, 108, 47, 10.1016/j.placenta.2021.03.011 Cnossen, 2008, Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis, CMAJ, 178, 701, 10.1503/cmaj.070430 MacDonald, 2018, Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study, BMC Pregnancy Childbirth, 18, 354, 10.1186/s12884-018-1992-x Hillesund, 2014, Development of a New Nordic Diet score and its association with gestational weight gain and fetal growth - a study performed in the Norwegian Mother and Child Cohort Study (MoBa), Public Health Nutr, 17, 1909, 10.1017/S1368980014000421 Cedergren, 2007, Optimal gestational weight gain for body mass index categories, Obstet Gynecol, 110, 759, 10.1097/01.AOG.0000279450.85198.b2 Vonck, 2019, Low volume circulation in normotensive women pregnant with neonates small for gestational age, Fetal Diagn Ther, 46, 238, 10.1159/000495507 Rolnik, 2017, Aspirin versus placebo in pregnancies at high risk for preterm Preeclampsia, N Engl J Med, 377, 613, 10.1056/NEJMoa1704559 Guy, 2021, Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study, BJOG, 128, 149, 10.1111/1471-0528.16361 Rolnik, 2022, Prevention of preeclampsia with aspirin, Am J Obstet Gynecol, 226, S1108, 10.1016/j.ajog.2020.08.045 Tan, 2018, Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE, Ultrasound Obstet Gynecol, 52, 52, 10.1002/uog.19077 Cruz-Lemini, 2022, Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis, Am J Obstet Gynecol, 226, S1126, 10.1016/j.ajog.2020.11.006 Rodger, 2016, Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials, Lancet, 388, 2629, 10.1016/S0140-6736(16)31139-4 Haddad, 2016, Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial, Obstet Gynecol, 128, 1053, 10.1097/AOG.0000000000001673 Groom, 2017, Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial, Am J Obstet Gynecol, 216, 296.e1, 10.1016/j.ajog.2017.01.014 Toal, 2007, Usefulness of a placental profile in high-risk pregnancies, Am J Obstet Gynecol, 196, 363.e1, 10.1016/j.ajog.2006.10.897 Lecarpentier, 2018, Angiogenic factor profiles in pregnant women with a history of early-onset severe preeclampsia receiving low-molecular-weight heparin prophylaxis, Obstet Gynecol, 131, 63, 10.1097/AOG.0000000000002380 Pels, 2020, Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial. JAMA, Netw Open, 3 Papageorghiou, 2016, International standards for symphysis-fundal height based on serial measurements from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: prospective cohort study in eight countries, BMJ, 355, i5662, 10.1136/bmj.i5662 Goto, 2013, Prediction of low birthweight and small for gestational age from symphysis-fundal height mainly in developing countries: a meta-analysis, J Epidemiol Community Health, 67, 999, 10.1136/jech-2012-202141 Imdad, 2011, Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduction of IUGR related stillbirths, BMC Public Health, 11, S1, 10.1186/1471-2458-11-S3-S1 Robert Peter, 2015, Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth, Cochrane Database Syst Rev, 2015, CD008136 2019, ACOG Practice Bulletin No. 204: Fetal growth restriction, Obstet Gynecol, 133, e97, 10.1097/AOG.0000000000003070 Gardosi, 1999, Controlled trial of fundal height measurement plotted on customised antenatal growth charts, Br J Obstet Gynaecol, 106, 309, 10.1111/j.1471-0528.1999.tb08267.x Dudley, 2005, A systematic review of the ultrasound estimation of fetal weight, Ultrasound Obstet Gynecol, 25, 80, 10.1002/uog.1751 Cody, 2016, The effect of maternal obesity on sonographic fetal weight estimation and perinatal outcome in pregnancies complicated by fetal growth restriction, J Clin Ultrasound, 44, 34, 10.1002/jcu.22273 Melamed, 2016, Choice of formula and accuracy of fetal weight estimation in small-for-gestational-age fetuses, J Ultrasound Med, 35, 71, 10.7863/ultra.15.02058 Proctor, 2010, Incorporation of femur length leads to underestimation of fetal weight in asymmetric preterm growth restriction, Ultrasound Obstet Gynecol, 35, 442, 10.1002/uog.7605 Kramer, 2001, A new and improved population-based Canadian reference for birth weight for gestational age, Pediatrics, 108, E35, 10.1542/peds.108.2.e35 Hadlock, 1991, In utero analysis of fetal growth: a sonographic weight standard, Radiology, 181, 129, 10.1148/radiology.181.1.1887021 Melamed, 2021, Diagnostic accuracy of fetal growth charts for placenta-related fetal growth restriction, Placenta, 105, 70, 10.1016/j.placenta.2021.01.022 Hiersch, 2021, Identification of the optimal growth chart and threshold for the prediction of antepartum stillbirth, Arch Gynecol Obstet, 303, 381, 10.1007/s00404-020-05747-4 Liauw, 2022, Which chart and which cut-point: deciding on the INTERGROWTH, World Health Organization, or Hadlock fetal growth chart, BMC Pregnancy Childbirth, 22, 25, 10.1186/s12884-021-04324-0 Sovio, 2015, Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study, Lancet, 386, 2089, 10.1016/S0140-6736(15)00131-2 Skråstad, 2013, A randomized controlled trial of third-trimester routine ultrasound in a non-selected population, Acta Obstet Gynecol Scand, 92, 1353, 10.1111/aogs.12249 Roma, 2015, Ultrasound screening for fetal growth restriction at 36 vs 32 weeks' gestation: a randomized trial (ROUTE), Ultrasound Obstet Gynecol, 46, 391, 10.1002/uog.14915 Henrichs, 2019, Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial, BMJ, 367, l5517, 10.1136/bmj.l5517 Wanyonyi, 2021, Routine third-trimester ultrasound for the detection of small-for-gestational age in low-risk pregnancies (ROTTUS study): randomized controlled trial, Ultrasound Obstet Gynecol, 57, 910, 10.1002/uog.23618 Caradeux, 2019, Diagnostic performance of third-trimester ultrasound for the prediction of late-onset fetal growth restriction: a systematic review and meta-analysis, Am J Obstet Gynecol, 220, 449, 10.1016/j.ajog.2018.09.043 Smith, 2021, Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis, Health Technol Assess, 25, 1, 10.3310/hta25150 Gaccioli, 2018, Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study, Lancet Child Adolesc Health, 2, 569, 10.1016/S2352-4642(18)30129-9 Sovio, 2020, A maternal serum metabolite ratio predicts fetal growth restriction at term, Nat Med, 26, 348, 10.1038/s41591-020-0804-9 Smith, 2021, Developing novel tests to screen for fetal growth restriction, Trends Mol Med, 27, 743, 10.1016/j.molmed.2021.05.006 Hiersch, 2018, Fetal growth velocity and body proportion in the assessment of growth, Am J Obstet Gynecol, 218, S700, 10.1016/j.ajog.2017.12.014 Wastlund, 2019, Screening for breech presentation using universal late-pregnancy ultrasonography: a prospective cohort study and cost effectiveness analysis, PLoS Med, 16, 10.1371/journal.pmed.1002778 Drukker, 2021, How often do we identify fetal abnormalities during routine third-trimester ultrasound? A systematic review and meta-analysis, BJOG, 128, 259, 10.1111/1471-0528.16468 Butt, 2019, Guideline No. 388-Determination of gestational age by ultrasound, J Obstet Gynaecol Can, 41, 1497, 10.1016/j.jogc.2019.04.010 Dall'Asta, 2020, Etiology and perinatal outcome of periviable fetal growth restriction associated with structural or genetic anomaly, Ultrasound Obstet Gynecol, 55, 368, 10.1002/uog.20368 van der Knoop, 2020, Additional value of advanced neurosonography and magnetic resonance imaging in fetuses at risk for brain damage, Ultrasound Obstet Gynecol, 56, 348, 10.1002/uog.21943 Khalil, 2020, ISUOG Practice Guidelines: role of ultrasound in congenital infection, Ultrasound Obstet Gynecol, 56, 128, 10.1002/uog.21991 Jauniaux, 1996, Prenatal diagnosis of triploidy during the second trimester of pregnancy, Obstet Gynecol, 88, 983, 10.1016/S0029-7844(96)00330-4 Fitzpatrick, 2022, A systematic review of maternal TORCH serology as a screen for suspected fetal infection, Prenat Diagn, 42, 87, 10.1002/pd.6073 Suhren, 2022, Meta-analysis on COVID-19-pregnancy-related placental pathologies shows no specific pattern, Placenta, 117, 72, 10.1016/j.placenta.2021.10.010 Dubucs, 2022, Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death, Hum Pathol, 121, 46, 10.1016/j.humpath.2021.12.012 Chmielewska, 2021, Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis, Lancet Glob Health, 9, e759, 10.1016/S2214-109X(21)00079-6 Wei, 2021, The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis, CMAJ, 193, E540, 10.1503/cmaj.202604 Yamamoto, 2013, Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction, J Obstet Gynaecol Res, 39, 653, 10.1111/j.1447-0756.2012.02012.x Snijders, 1993, Fetal growth retardation: associated malformations and chromosomal abnormalities, Am J Obstet Gynecol, 168, 547, 10.1016/0002-9378(93)90491-Z Tzadikevitch Geffen, 2021, The yield of chromosomal microarray in pregnancies complicated with fetal growth restriction can be predicted according to clinical parameters, Fetal Diagn Ther, 48, 140, 10.1159/000511475 Benton, 2016, Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction, Placenta, 42, 1, 10.1016/j.placenta.2016.03.010 Figueras, 2014, Stage-based approach to the management of fetal growth restriction, Prenat Diagn, 34, 655, 10.1002/pd.4412 Figueras, 2018, Diagnosis and surveillance of late-onset fetal growth restriction, Am J Obstet Gynecol, 218, S790, 10.1016/j.ajog.2017.12.003 Levytska, 2017, Placental pathology in relation to uterine artery Doppler findings in pregnancies with severe intrauterine growth restriction and abnormal umbilical artery Doppler changes, Am J Perinatol, 34, 451 Korzeniewski, 2016, Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study, Am J Obstet Gynecol, 214, 629.e1, 10.1016/j.ajog.2015.11.015 Ashwal, 2022, The accuracy of fetoplacental Doppler in distinguishing between growth restricted and constitutionally small fetuses, Placenta, 120, 40, 10.1016/j.placenta.2022.02.007 Sagi-Dain, 2018, Chromosomal microarray analysis results from pregnancies with various ultrasonographic anomalies, Obstet Gynecol, 132, 1368, 10.1097/AOG.0000000000002975 Borrell, 2018, Chromosomal microarray analysis in fetuses with growth restriction and normal karyotype: a systematic review and meta-analysis, Fetal Diagn Ther, 44, 1, 10.1159/000479506 Leytes, 2020, Procedure-to-delivery interval after late amniocentesis and the need for routine antenatal corticosteroids, J Matern Fetal Neonatal Med, 35, 4338, 10.1080/14767058.2020.1849115 Iliodromiti, 2017, Customised and noncustomised birth weight centiles and prediction of stillbirth and infant mortality and morbidity: a cohort study of 979,912 term singleton pregnancies in Scotland, PLoS Med, 14, 10.1371/journal.pmed.1002228 Poon, 2021, Int J Gynaecol Obstet, 154, 3, 10.1002/ijgo.13763 Crimmins, 2014, A comparison of Doppler and biophysical findings between liveborn and stillborn growth-restricted fetuses, Am J Obstet Gynecol, 211, 669.e1, 10.1016/j.ajog.2014.06.022 Baschat, 2003, Integrated fetal testing in growth restriction: combining multivessel Doppler and biophysical parameters, Ultrasound Obstet Gynecol, 21, 1, 10.1002/uog.21 Hecher, 2001, Monitoring of fetuses with intrauterine growth restriction: a longitudinal study, Ultrasound Obstet Gynecol, 18, 564, 10.1046/j.0960-7692.2001.00590.x Turan, 2008, Progression of Doppler abnormalities in intrauterine growth restriction, Ultrasound Obstet Gynecol, 32, 160, 10.1002/uog.5386 Oros, 2011, Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-for-gestational age fetuses, Ultrasound Obstet Gynecol, 37, 191, 10.1002/uog.7738 Unterscheider, 2013, Predictable progressive Doppler deterioration in IUGR: does it really exist?, Am J Obstet Gynecol, 209, 539.e1, 10.1016/j.ajog.2013.08.039 Ferrazzi, 2002, Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus, Ultrasound Obstet Gynecol, 19, 140, 10.1046/j.0960-7692.2002.00627.x Lees, 2015, 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial, Lancet, 385, 2162, 10.1016/S0140-6736(14)62049-3 Melamed, 2016, Antenatal corticosteroids and outcomes of small-for-gestational-age neonates, Obstet Gynecol, 128, 1001, 10.1097/AOG.0000000000001674 Edwards, 2003, Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone, Placenta, 24, 12, 10.1053/plac.2002.0874 Simchen, 2004, The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction, Am J Obstet Gynecol, 190, 296, 10.1016/j.ajog.2003.08.011 Boers, 2010, Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT), BMJ, 341, c7087, 10.1136/bmj.c7087 Meler, 2021, Ten-year experience of protocol-based management of small-for-gestational-age fetuses: perinatal outcome in late-pregnancy cases diagnosed after 32 weeks, Ultrasound Obstet Gynecol, 57, 62, 10.1002/uog.23537 Zhu, 2016, The hemodynamics of late-onset intrauterine growth restriction by MRI, Am J Obstet Gynecol, 214, 367.e1, 10.1016/j.ajog.2015.10.004 Shah, 2012, Prediction of survival without morbidity for infants born at under 33 weeks gestational age: a user-friendly graphical tool, Arch Dis Child Fetal Neonatal Ed, 97, F110, 10.1136/archdischild-2011-300143 Selvaratnam, 2021, Association between iatrogenic delivery for suspected fetal growth restriction and childhood school outcomes, JAMA, 326, 145, 10.1001/jama.2021.8608 Conde-Agudelo, 2018, Predictive accuracy of cerebroplacental ratio for adverse perinatal and neurodevelopmental outcomes in suspected fetal growth restriction: systematic review and meta-analysis, Ultrasound Obstet Gynecol, 52, 430, 10.1002/uog.19117 Flood, 2014, The role of brain sparing in the prediction of adverse outcomes in intrauterine growth restriction: results of the multicenter PORTO Study, Am J Obstet Gynecol, 211, 288.e1, 10.1016/j.ajog.2014.05.008 Shinohara, 2017, Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction, Hypertens Pregnancy, 36, 269, 10.1080/10641955.2017.1334800 Chappell, 2019, Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial, Lancet, 394, 1181, 10.1016/S0140-6736(19)31963-4 Skoll, 2018, No. 364-antenatal corticosteroid therapy for improving neonatal outcomes, J Obstet Gynaecol Can, 40, 1219, 10.1016/j.jogc.2018.04.018 Stockley, 2018, Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses, Am J Obstet Gynecol, 219, 606.e1, 10.1016/j.ajog.2018.09.010 Magee, 2019, No. 376-magnesium sulphate for fetal neuroprotection, J Obstet Gynaecol Can, 41, 505, 10.1016/j.jogc.2018.09.018 Brown, 2022, Delayed cord clamping in small for gestational age preterm infants, Am J Obstet Gynecol, 226, 247.e1, 10.1016/j.ajog.2021.08.003 McDonald, 2022, Guideline No. 424: Umbilical cord management in preterm and term infants, J Obstet Gynaecol Can, 44, 313, 10.1016/j.jogc.2022.01.007 Jasani, 2021, Association of umbilical cord management strategies with outcomes of preterm infants: a systematic review and network meta-analysis, JAMA Pediatr, 175, 10.1001/jamapediatrics.2021.0102 Ting, 2018, Antenatal glucocorticoids, magnesium sulfate, and mode of birth in preterm fetal small for gestational age, Am J Obstet Gynecol, 218, S818, 10.1016/j.ajog.2017.12.227 Shinar, 2021, Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction, Pregnancy Hypertens, 25, 123, 10.1016/j.preghy.2021.05.023 Lin, 1981, Oxytocin challenge test and intrauterine growth retardation, Am J Obstet Gynecol, 140, 282, 10.1016/0002-9378(81)90274-X Dore, 2020, No. 396-fetal health surveillance: intrapartum consensus guideline, J Obstet Gynaecol Can, 42, 316, 10.1016/j.jogc.2019.05.007 Zur, 2020, The placental basis of fetal growth restriction, Obstet Gynecol Clin North Am, 47, 81, 10.1016/j.ogc.2019.10.008 Jago, 2021, Mental health and maternal mortality-when new life doesn't bring Joy, J Obstet Gynaecol Can, 43, 67, 10.1016/j.jogc.2020.06.016 Accortt, 2022, Association between diagnosed perinatal mood and anxiety disorders and adverse perinatal outcomes, J Matern Fetal Neonatal Med, 35, 9066, 10.1080/14767058.2021.2014450 Ray, 2017, Mortality in infants affected by preterm birth and severe small-for-gestational age birth weight, Pediatrics, 140, 10.1542/peds.2017-1881 Bhargava, 2004, Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood, N Engl J Med, 350, 865, 10.1056/NEJMoa035698 Smith, 2001, Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births, Lancet, 357, 2002, 10.1016/S0140-6736(00)05112-6 Ananth, 2009, Recurrence of fetal growth restriction in singleton and twin gestations, J Matern Fetal Neonatal Med, 22, 654, 10.1080/14767050902740207 Brady, 2021, Immunomodulatory therapy reduces the severity of placental lesions in chronic histiocytic intervillositis, Front Med (Lausanne), 8 Derricott, 2016, Characterizing villitis of unknown etiology and inflammation in stillbirth, Am J Pathol, 186, 952, 10.1016/j.ajpath.2015.12.010 Andrikopoulou, 2018, Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women, Am J Obstet Gynecol, 219, 399.e1, 10.1016/j.ajog.2018.06.011 Franco, 2011, Placental infarction and thrombophilia, Obstet Gynecol, 117, 929, 10.1097/AOG.0b013e31820ca040 Kingdom, 2011, Is heparin a placental anticoagulant in high-risk pregnancies?, Blood, 118, 4780, 10.1182/blood-2011-07-319749 Ashwal, 2023, Predictive accuracy of early mid-trimester placental markers for recurrence of placenta-mediated pregnancy complications. Ultrasound Obstet Gynecol in press, Blood, 61, 418 Guy, 2022, Effect of routine first-trimester combined screening for pre-eclampsia on small-for-gestational-age birth: a secondary interrupted time series analysis, Ultrasound Obstet Gynecol, 59, 55, 10.1002/uog.23741 Myers, 2013, Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study, BJOG, 120, 1215, 10.1111/1471-0528.12195 Audette, 2021, Second trimester placental growth factor levels and placental histopathology in low-risk nulliparous pregnancies, J Obstet Gynaecol Can, 43, 1145, 10.1016/j.jogc.2021.01.018 Cluver, 2021, Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial, BMJ, 374, n2103, 10.1136/bmj.n2103 Toal, 2008, Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images, Am J Obstet Gynecol, 198, 330.e1, 10.1016/j.ajog.2007.09.031 Crispi, 2008, Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction, Ultrasound Obstet Gynecol, 31, 303, 10.1002/uog.5184